Literature DB >> 17400665

Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients.

Eduardo S Darze1, Adriana L Latado, Aloyra G Guimarães, Rodrigo A V Guedes, Alessandra B Santos, Simone S de Moura, Luiz Carlos Santana Passos.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is a well-recognized risk factor for venous thromboembolism (VTE) and is associated with higher mortality in patients with an acute pulmonary embolism (PE). There are very few data on how acute PE affects the clinical course of patients with heart failure. The purpose of this study was to determine the impact of an acute PE on the short-term prognosis of patients hospitalized for decompensated CHF.
METHODS: This was a prospective cohort study of 198 patients admitted to a coronary care unit between July 2001 and March 2003 with severe decompensated CHF. The primary outcome measure was death or rehospitalization at 3 months.
RESULTS: PE was confirmed in 18 of 198 patients enrolled (9.1%). The groups with and without PE were comparable with regards to demographics, the prevalence of comorbid conditions, and severity of CHF (p > 0.05). The prevalence of cancer (p = 0.0001), previous VTE (p = 0.003), and right ventricular overload (p = 0.006) was higher in the PE group. The presence of PE was also associated with a longer hospital stay (37.5 +/- 71.6 days vs 15.4 +/- 15.0 days, p = 0.001) [mean +/- SD] and a higher incidence of death or rehospitalization at 3 months (72.2% vs 43.9%, p = 0.02). In a multiple logistic regression analysis, PE remained an independent predictor of death or rehospitalization at 3 months (odds ratio, 4.0; 95% confidence interval, 1.1 to 15.1; p = 0.038).
CONCLUSIONS: Acute PE commonly complicates the hospital course of patients with severe CHF, increasing the length of hospital stay and the chance of death or rehospitalization at 3 months.

Entities:  

Mesh:

Year:  2007        PMID: 17400665     DOI: 10.1378/chest.06-2077

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure.

Authors:  Ali Zorlu; Mehmet Birhan Yilmaz; Hasan Yucel; Gokhan Bektasoglu; Meltem Refiker Ege; Izzet Tandogan
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Predictors of medium- and long-term mortality in elderly patients with acute pulmonary embolism.

Authors:  Hernan Polo Friz; Annalisa Orenti; Elia Gelfi; Elena Motto; Laura Primitz; Luca Cavalieri d'Oro; Cristina Giannattasio; Giuseppe Vighi; Claudio Cimminiello; Patrizia Boracchi
Journal:  Heliyon       Date:  2020-09-14

Review 3.  Safety and efficacy of new anticoagulants in patients with heart failure.

Authors:  Ron Pisters; Gregory Y H Lip
Journal:  Curr Heart Fail Rep       Date:  2013-03

4.  Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination.

Authors:  Ranjith Shetty; Ali Seddighzadeh; Gregory Piazza; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2007-10-17       Impact factor: 2.300

5.  Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.

Authors:  Christina L Fanola; Faye L Norby; Amil M Shah; Patricia P Chang; Pamela L Lutsey; Wayne D Rosamond; Mary Cushman; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2020-01-21       Impact factor: 24.094

Review 6.  Role of antithrombotic agents in heart failure.

Authors:  John G F Cleland; Saqib Mumtaz; Luca Cecchini
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 7.  Reduced cardiac function and risk of venous thromboembolism in Asian countries.

Authors:  Ruiqi Zhu; Liang Tang; Yu Hu
Journal:  Thromb J       Date:  2017-04-24

8.  The significance of mitral and tricuspid valve systolic lateral annular velocities in the diagnosis of acute pulmonary embolism in patients with chronic heart failure.

Authors:  Leszek Gromadziński; Ryszard Targoński; Beata Januszko-Giergielewicz; Philip Ostrowski; Piotr Pruszczyk
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

9.  Treatment of Pulmonary Tumor Embolism from Choriocarcinoma: Extracorporeal Membrane Oxygenation as a Bridge through Chemotherapy.

Authors:  Jae Heun Chung; Hye Ju Yeo; Hyun Myung Cho; Jin Ook Jang; Byung Min Ye; Gun Yoon; Dong Hoon Shin; Dohyung Kim; Woo Hyun Cho
Journal:  Cancer Res Treat       Date:  2016-06-24       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.